A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is recognized as a classic clonal myeloproliferative disorder. Given the limited treatment options for CML patients in the accelerated phase (AP) and blast phase (BP), there is an evident need to develop new therapeutic strategies. This has the potential to improve out...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mengting, Fang, Xiaocui, Du, Rong, Meng, Jie, Liu, Jingyi, Liu, Mingpeng, Yang, Yanlian, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534672/
https://www.ncbi.nlm.nih.gov/pubmed/37765274
http://dx.doi.org/10.3390/pharmaceutics15092305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534672/
https://www.ncbi.nlm.nih.gov/pubmed/37765274
http://dx.doi.org/10.3390/pharmaceutics15092305

Ejemplares similares